Methotrexate (2.5mg tablets)

Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Brand:
NICE TA:
Indication: Rheumatic diseases
Disease category: Musculoskeletal and joint diseases
Commissioning responsibility: CCG
PbR excluded: No

Background

LMMG is adopting the local decisions made prior to April 2013

Recommendation

LMMG recommendation: Amber2
Click here to find the definitions for the colour classifications

Reason for decision: Requires significant monitoring

Supporting documents:

Methotrexate Shared Care Guideline (Version 2.1) (146.4 KiB)

DMARDs Shared Care Agreement V1.1 (124.0 KiB)

**Please note - For Fylde & Wyre CCG DMARD Shared Care Guidelines please use the versions available on the CCG website

**Please note - For Blackpool CCG DMARD Shared Care Guidelines please use the versions available on the CCG website

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG	NHS Blackpool CCG	NHS Chorley and South Ribble CCG and NHS Greater Preston CCG	NHS Fylde and Wyre CCG	NHS Morecambe Bay CCG	NHS West Lancashire CCG
Amber2	Amber2	Amber2	Amber2	Amber2	Amber2

Medicines